In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]

John Gordon, Nicholas Barnes, Elisabeth Meredith, Mark Drayson

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)e1-e3
JournalBiochemical Pharmacology
Issue number6
Publication statusPublished - 15 Mar 2008

Cite this